Skip to main content
Presentation
The Effect of Certolizumab Pegol on Radiographic Progression Over 4 Years of Treatment in Patients with Psoriatic Arthritis. German Society of Rheumatology, (DGRh) 2017, Stuttgart, Germany, September 2017.
German Society of Rheumatology, (DGRh) (2017)
  • D van der Heijde
  • Robert Fleischmann
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
September, 2017
Citation Information
D van der Heijde, Robert Fleischmann, Philip Mease and et.al.. "The Effect of Certolizumab Pegol on Radiographic Progression Over 4 Years of Treatment in Patients with Psoriatic Arthritis. German Society of Rheumatology, (DGRh) 2017, Stuttgart, Germany, September 2017." German Society of Rheumatology, (DGRh) (2017)
Available at: http://works.bepress.com/philip-mease/218/